1/26/2023 Dr. Paul T. Finger has been named a Top Doctor for 2023! Eye Care Foundation is proud to congratulate our Founder and Chairman, Dr. Paul T. Finger, on being named a Castle Connolly top doctor of 2023! Dr. Finger has over 35 years of experience in the world of ophthalmology. Not only has he invented tools that help...
1/24/2023 The Eye Cancer Foundation is Awarded the 2023 Platinum Seal Award! For the fourth year in a row, The Eye Cancer Foundation has been awarded the Platinum Seal of Transparency by Candid, the leading source of information on non-profits within the United States. The ECF is pleased that donors, current and prospective, are...
1/19/2023 Tarsoconjunctival Flag for Scleromalacia Related to Treatments for Conjunctival Melanoma Drs. Paul T. Finger, Harsha S. Reddy and Abhilasha Maheshwari have just published in the American Journal of Ophthalmology Case Reports. They describe the first use of a tarsoconjunctival pedicle flap for the repair of...
11/23/2022 Winter 2022 Visionary Out Now! While recovering from the devastating effects of the pandemic, the ECF’s mission and values remain the same. This year has been the year of restarting, fellows returning to our world-wide training centers to continue their research work, expansion of our scientific advisory board, and exponential...
09/23/2022 Congratulations to Dr. Sonal P. Yadav for releasing her new book! Dr. Sonal P. Yadav, a prominent member and doctor of The Eye Cancer Network, has published her book on retinoblastoma! About the book: Retinoblastoma is a unique malignancy. Unlike most of the solid tumors of the human body, retino...
09/20/2022 Dr. Alberto Calle-Vásquez inducted into the Scientific Advisory Board As of September 2022, Dr. C. Alberto Calle-Vásquez has been inducted onto the Scientific Advisory Board for the Eye Cancer Foundation! Below you can find his bio. Dr. Alberto Calle-Vásquez, MD, FACS is an Associate Professor of Ophthalmology...
09/06/2022 New Published Article for the British Journal of Ophthalmology Written by Drs. Paul T. Finger, Abhilasha Maheshwari, and Codrin Iacob, this article published to the British Jorunal of Ophthalmology describes the management of patients with occult anterior uveal melanomas presenting with extrascleral extension...
08/15/2022 Congrats to Dr. Javiera Araya Cohen Dr. Javiera Araya Cohen, MD, came to The New York Eye Cancer Center and completed an International Observership under Dr. Paul T. Finger! This fellowship lasted from July 14, 2022- August 14, 2022. During her one month here, Dr. Javiera observed Dr. Finger and learned a variety of new...
07/10/2022 ASRS 40th Annual Meeting In a presentation for ASRS, Dr. Finger presents eye cancer supported research involving retrospective, international, multi-center analysis of 2190 RB patients investigating whether clinical features and tumor size can predict high-risk pathological features (HRPF) and thus risk of metastatic...
07/01/2022 Congratulations to Dr. Abhilasha Maheshwari on completion of her fellowship! Abhilasha Maheshwari MD, returned to The New York Eye Cancer Center for a Clinical Research Fellowship, having completed an astounding 10 projects. Several are “In Press”, but all are impressive! To list some...
06/09/2022 Join us for the 44th Annual Tulane Eye Alumni Day! Join us by ZOOM as Dr. Ankit Singh Tomar presents Tulane’s Paul T. Finger, MD lecture in Ophthalmic Oncology at the 44th Annual Tulane Alumni Day in New Orleans, USA. He will be speaking on the recent results of the AJCC-OOTF Retinoblastoma Registry...
05/12/2022 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multi-center Registry-based Study Retinoblastoma is the most common childhood eye cancer. Though potentially curable at early stages, a significant proportion of cases arise in Asia and Africa...
04/29/2022 Dr. Paul T. Finger has been named one of New York Metro's Top Doctors of 2022! The Eye Care Foundation is proud to congratulate our Founder and Chairman, Dr. Paul T. Finger, on being named one of the top doctors of 2022! Dr. Finger has been a prominent figure in the ophthalmology world. Not only has he...
04/21/2022 High-Risk Pathology Based on Presenting Features in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing AJCC Study Retinoblastoma is the most common eye cancer in childhood. Timely diagnosis and protocol-based management can achieve excellent survival. However, the...
03/25/2022 The Spring 2022 Visionary is here The Eye Cancer Foundation publishes The Visionary free-of-charge to keep you informed about the latest news, research, and global efforts focused on improving eye cancer treatment, diagnosis, and cure. In this edition, you will find articles about: The 2022 fellows' successful training...
2/25/2022 The Eye Cancer Foundation is awarded the 2022 Platinum Seal Award For the third year in a row, The Eye Cancer Foundation has been awarded the Platinum Seal of Transparency by GuideStar, the leading source of information on non-profits within the United States. The ECF is pleased that donors, current and...
2/04/2022 World Cancer Day: World Retinoblastoma Awareness In honor of World Cancer Day, Dr. Finger and Dr. Yacoub Yousef have created and presented an informational video about Retinoblastoma treatment around the world, and what needs to be improved to maximize on care for eye cancer patients...
2/03/2022 The ECF would like to congratulate Dr. Vincent Sun on completion of his fellowship! From July 1st 2021 to February 1st 2022, Dr. Vincent Sun trained under Dr. Paul Finger in New York to complete a fellowship in ocular tumor, orbital disease and ophthalmic radiation therapy! While in New York City, Dr. Sun exhibited...
1/28/2022 Retinoblastoma Outcomes: A Global Perspective Retinoblastoma is the most common pediatric eye cancer, and is typically curable through early diagnosis and protocol-based management. In fact, advanced medical care delivery in high-income regions has provided excellent rates of survival, and globe...
1/04/2022 Patients presenting with Stage IV uveal melanoma Patients presenting with choroidal melanoma must be checked for metastatic “Stage IV” melanoma before their eye surgery. What makes this difficult is that in the modern era, almost all patients have no symptoms and most centers only check the liver for metastasis...
